The Latest

Pressure Mounts on Truvada PrEP Pricing With Lawsuit and Congressional Hearings

"This isn't about you," Rep. Alexandria Ocasio-Cortez (D-NY) told Gilead CEO Daniel O'Day. "We have legislated a system that allows [this] to happen."

By Tim Murphy

Will Recent Gilead Patent Concessions on Truvada Lower PrEP Prices?

Activists say this relatively small giveaway won't advance PrEP access or help end HIV in the U.S. the way a true price reduction would.

By Tim Murphy

Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

But a survey reveals that about a third of black and Latino gay men would be willing to pay more than $50 per month for a prescription.

By Sony Salzman

PrEP Pricing Is the Elephant in the Room at the CDC National HIV Prevention Conference

In a debate during a plenary session, Michael Saag, M.D., argued for more activism to make PrEP accessible to people who need it.

By Sony Salzman

For HIV, Treatment is Prevention

The director of the U.S. National Institutes of Health talks about a newly published expert article explaining that sexual transmission of HIV can't happen if a person is on fully effective treatment.

By Francis Collins, M.D., Ph.D. for U.S. National Institutes of Health

Jordan Eagles Uses Life's Blood in Life's Work

Many creative folk say that art is in their blood. For Jordan Eagles, blood is in his art -- not simply as an artistic tool, but as a precious, universal life force.

By Charles Sanchez

Stop Blaming PrEP for the Rise in STIs -- the Picture Is More Complex Than That

"PrEP must not be cast as the lone villain in the syphilis crisis, nor MSM engaging in chemsex cast as debauched vectors of transmission."

By Oli Stevens and T Charles Witzel for The Conversation

States Innovate to Expand PrEP Availability and Uptake

As part of comprehensive efforts to reduce the number of new HIV infections, some states are innovating to make HIV pre-exposure prophylaxis (PrEP) more accessible to individuals at high risk of HIV.

By HIV.gov

The U.S. Takes a First but Long Overdue Step Toward Building a National PrEP Program

On Nov. 20, 2018, the U.S. Preventive Services Task Force released a draft recommendation that could transform HIV-1 pre-exposure prophylaxis (PrEP) scale-up in the United States.

By Christian Antonio Urrutia and James Krellenstein

'I Am Detectable': One Man's Story

Usually not just one issue, but a combination of challenges, leads to gaps in care -- and a detectable viral load.

By Charles Sanchez